Grünenthal Gmbh

This study tested whether repeated injections of an experimental drug called RTX-GRT7039 could safely reduce pain in adults with knee osteoarthritis. About 469 participants who still had significant pain despite standard treatments received either the drug or a placebo injection …

This study tested the safety of a new injection called RTX-GRT7039 for people with moderate to severe knee pain from osteoarthritis. It involved 714 adults whose standard pain treatments weren't working well enough. The main goal was to see how safe and tolerable the injections w…

This large, completed Phase 3 trial tested whether a single injection into the knee joint could safely reduce pain for people with osteoarthritis. It compared the experimental injection, called RTX-GRT7039, against a placebo (a dummy injection) in 466 adults whose knee pain wasn'…

This early-stage study tested the safety and how the body processes a single dose of an experimental drug called GRT6019 in 18 healthy male volunteers. Researchers specifically checked if taking the drug with food versus on an empty stomach changed how it was absorbed. The goal w…